Researchers at Dongguk University have developed a new method for controlling gene expression using electromagnetic fields. Traditional gene switches often rely on drugs, light, or heat, which can be invasive or lack the necessary precision for medical applications. This new tool allows for remote, non-invasive, and fully reversible control of specific genes, marking a shift in how scientists approach genetic therapy.
The team focused on the Lgr4 gene promoter, which reacts to electromagnetic field exposure. By using a 2.0 millitesla field at 60 hertz, the researchers triggered specific gene activation without causing adverse effects in test subjects. When the electromagnetic field is turned off, gene expression returns to baseline within 24 hours. This level of control provides a level of tunability that current methods struggle to achieve.
To understand how this mechanism functions, the team identified the protein Cyb5b as a biological sensor. This protein detects electromagnetic fields and initiates rhythmic calcium influxes, which act as a signal to turn the target gene on or off. This discovery provides a clear look at how cells respond to electromagnetic stimuli at a molecular level.
Practical applications of this technology show promise for future medical treatments. In mouse models, the team successfully used the switch to decouple brain aging from amyloid plaque deposition in Alzheimer's studies. They also used it to reverse cellular aging markers and restore serotonin levels to reduce depression-like behaviors. These results indicate that future gene therapies might move away from one-time irreversible doses toward real-time, managed treatments.
While this work remains in the research phase, it suggests that clinicians could one day manage genetic disorders through non-invasive external devices. The ability to precisely control gene activity without surgical intervention or chemical delivery systems represents a significant step in developing targeted therapeutic strategies.